Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126406134 | 12640613 | 4 | F | 20160822 | 20160810 | 20160902 | EXP | GB-PFIZER INC-2016377634 | PFIZER | 0.00 | F | Y | 0.00000 | 20160902 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126406134 | 12640613 | 1 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126406134 | 12640613 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126406134 | 12640613 | 3 | PS | Doxorubicin | DOXORUBICIN | 1 | Unknown | UNK | U | 50467 | |||||||||
| 126406134 | 12640613 | 4 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Unknown | UNK | U | 71484 | |||||||||
| 126406134 | 12640613 | 5 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126406134 | 12640613 | 1 | Diffuse large B-cell lymphoma |
| 126406134 | 12640613 | 2 | Diffuse large B-cell lymphoma |
| 126406134 | 12640613 | 3 | Diffuse large B-cell lymphoma |
| 126406134 | 12640613 | 4 | Diffuse large B-cell lymphoma |
| 126406134 | 12640613 | 5 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126406134 | 12640613 | HO |
| 126406134 | 12640613 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126406134 | 12640613 | Body temperature increased | |
| 126406134 | 12640613 | Diffuse large B-cell lymphoma | |
| 126406134 | 12640613 | Disease progression | |
| 126406134 | 12640613 | Infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |